Healthcare & Life Sciences: Drug Pricing Digest - August 2021 #3

Drug Pricing Initiatives: On Aug. 24, 2021, the House of Representatives approved a $3.5 trillion budget framework, S. Cons. Res. 14, while also voting to advance the $1 trillion infrastructure bill. The deadline for the House to pass the infrastructure bill is Sept. 27, 2021. The Senate adopted a version of the infrastructure bill earlier this month, H.R. 3684 (the Investing in a New Vision for the Environment and Surface Transportation in America Act, or the INVEST in America Act). For more on the INVEST in America Act, see the August 16 issue of this digest.

In this context, House Democrats continue to discuss H.R. 3 (the Elijah E. Cummings Lower Drug Costs Now Act), which, among other things, would empower the Department of Health and Human Services (HHS) to negotiate drug prices directly with manufacturers, subject to a cap based on international reference pricing. The budget reconciliation process allows passage in both chambers by a simple majority, providing an opportunity for the Democratic majority to advance President Biden’s policy initiatives, including with respect to drug pricing.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP
Contact
more
less

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide